TG Therapeutics, Inc. (TGTX)
NASDAQ · Healthcare
TG Therapeutics, Inc. Net Income 2020–2025
TG Therapeutics, Inc. annual/quarterly net income history and growth rate from 2020 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- TG Therapeutics, Inc. net income for the quarter ending March 31, 2026 was 19.8 M, a 290.85% increase year-over-year.
- TG Therapeutics, Inc. net income for the twelve months ending March 31, 2026 was 461.9 M.
- TG Therapeutics, Inc. annual net income for 2025 was 447.2 M, a 1812.41% increase from 2024.
- TG Therapeutics, Inc. annual net income for 2024 was 23.4 M, a 84.52% increase from 2023.
- TG Therapeutics, Inc. annual net income for 2023 was 12.7 M, a 106.39% decrease from 2022.
- TG Therapeutics, Inc. annual net income for 2022 was -198.3 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
TG Therapeutics, Inc. Net Income — FAQ
TG Therapeutics, Inc. (TGTX) net income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is TG Therapeutics, Inc.'s net income?
TG Therapeutics, Inc. (TGTX) reported net income of $447M for fiscal 2025.
Where can I see TGTX's net income history?
The chart and table above show TG Therapeutics, Inc.'s net income by year and by quarter, including the growth rate.